pET21b-RBD-JA1
(Plasmid
#167126)
-
PurposeExpresses SARS-CoV-2 RBD in bacterial system
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 167126 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET21b(+)
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5442
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameSARS-CoV-2 Receptor Binding domain
-
SpeciesSARS-CoV-2
-
Insert Size (bp)596
-
Mutationresidues (333 to 529 aa)
-
GenBank IDYP_009724390.1
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
- Promoter T7
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer T7 Fwd
- 3′ sequencing primer T7 Term (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bycloned from Addgene
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET21b-RBD-JA1 was a gift from David Margulies (Addgene plasmid # 167126 ; http://n2t.net/addgene:167126 ; RRID:Addgene_167126) -
For your References section:
Synthetic nanobody-SARS-CoV-2 receptor-binding domain structures identify distinct epitopes. Ahmad J, Jiang J, Boyd LF, Natarajan K, Margulies DH. bioRxiv. 2021 Jan 27. doi: 10.1101/2021.01.27.428466. 10.1101/2021.01.27.428466 PubMed 33532775